Akero Therapeutics, Inc. (AKRO) Covered Calls

You can sell covered calls on Akero Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AKRO (prices last updated Thu 4:16 PM ET):

Akero Therapeutics, Inc. (AKRO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
19.77 +0.71 19.52 20.42 1.1M - 1.1
Covered Calls For Akero Therapeutics, Inc. (AKRO)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Dec 15 20 0.65 19.77 1.2% 48.7%
Jan 19 20 1.60 18.82 6.3% 52.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.